SOPHiA GENETICS Reports Financial Results for the Third Quarter of Fiscal 2022
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
SOPHiA GENETICS SA (SOPH) Reports In-Line Q3 EPS
November 8, 2022 7:27 AM ESTSOPHiA GENETICS SA (NASDAQ: SOPH) reported Q3 EPS of ($0.36), in-line with the analyst estimate of ($0.36). Revenue for the quarter came in at $11.6 million versus the consensus estimate of $11.45 million.
2022 Outlook:
We are reaffirming our previously provided guidance of constant... More
